Advisors Asset Management Inc. trimmed its stake in shares of Alteryx, Inc. (NYSE:AYX – Get Rating) by 39.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,103 shares of the company’s stock after selling 2,010 shares during the period. Advisors Asset Management Inc.’s holdings in Alteryx were worth $150,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the stock. Capital World Investors lifted its holdings in shares of Alteryx by 11.2% during the first quarter. Capital World Investors now owns 8,029,902 shares of the company’s stock valued at $574,379,000 after purchasing an additional 806,018 shares during the last quarter. Vanguard Group Inc. raised its position in Alteryx by 0.3% during the first quarter. Vanguard Group Inc. now owns 5,522,028 shares of the company’s stock valued at $394,991,000 after buying an additional 14,129 shares during the period. Mackenzie Financial Corp raised its position in Alteryx by 3.8% during the first quarter. Mackenzie Financial Corp now owns 2,473,630 shares of the company’s stock valued at $176,939,000 after buying an additional 91,182 shares during the period. Ardevora Asset Management LLP raised its position in Alteryx by 10.1% during the second quarter. Ardevora Asset Management LLP now owns 930,375 shares of the company’s stock valued at $45,049,000 after buying an additional 85,075 shares during the period. Finally, Vitruvian Partners LLP raised its position in Alteryx by 63.3% during the first quarter. Vitruvian Partners LLP now owns 819,547 shares of the company’s stock valued at $49,583,000 after buying an additional 317,826 shares during the period. 76.74% of the stock is owned by hedge funds and other institutional investors.
Alteryx Stock Performance
Shares of NYSE AYX opened at $43.44 on Tuesday. The company has a debt-to-equity ratio of 5.07, a quick ratio of 1.60 and a current ratio of 1.60. The firm has a market cap of $3.00 billion, a price-to-earnings ratio of -9.11 and a beta of 0.60. The business’s 50-day simple moving average is $52.23 and its 200-day simple moving average is $54.57. Alteryx, Inc. has a 52 week low of $40.57 and a 52 week high of $76.35.
Analyst Ratings Changes
Several research firms recently weighed in on AYX. Rosenblatt Securities upped their price target on Alteryx from $75.00 to $77.00 and gave the company a “buy” rating in a research report on Wednesday, August 3rd. Truist Financial reissued a “buy” rating and set a $80.00 price target on shares of Alteryx in a research report on Friday, November 11th. JMP Securities dropped their price target on Alteryx from $127.00 to $95.00 and set a “market outperform” rating on the stock in a research report on Wednesday, November 2nd. Citigroup upped their price target on Alteryx from $73.00 to $75.00 in a research report on Wednesday, November 2nd. Finally, Piper Sandler dropped their target price on Alteryx from $70.00 to $62.00 and set an “overweight” rating on the stock in a research report on Thursday, October 20th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $74.27.
Alteryx, Inc operates in analytic process automation business in the Asia-Pacific, Europe, the Middle East, Africa, Latin America, and internationally. The company's analytics platform enables organizations to enhance business outcomes and the productivity of their business analysts, data scientists, citizen data scientists, and data engineers.
- Get a free copy of the StockNews.com research report on Alteryx (AYX)
- Three Ways To Win The Online Gambling Industry
- Santa Claus Rally? Here’s What Needs to Happen
- Is Ardelyx is A Buy After Slip in Early 2022
- Will the Return of Bob Iger Return the Magic to Disney Stock?
- Is Tesla A Bargain Now As It Trades At Two-Year Lows?
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.